Ritonavir 相關新聞

← 返回新聞總覽


Ritonavir 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Ritonavir 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV 1 infected patients (adults and children of 2 years of age and older).
  • 證據等級:L5
  • 預測適應症(20 個):
    • HIV infectious disease(100.0%)
    • simian immunodeficiency virus infection(99.9%)
    • feline acquired immunodeficiency syndrome(99.9%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter(99.9%)
    • obsolete familial combined hyperlipidemia(99.8%)
    • chronic hepatitis C virus infection(99.5%)
    • AIDS(98.4%)
    • hepatitis B virus infection(98.1%)
    • hepatitis C virus infection(96.9%)
    • AIDS related complex(96.7%)
    • congenital human immunodeficiency virus(96.7%)
    • chronic hepatitis B virus infection(96.4%)
    • fibroma of prostate(95.8%)
    • hepatitis E virus infection(95.5%)
    • hepatitis, viral, animal(95.5%)
    • hepatitis A virus infection(95.4%)
    • Omsk hemorrhagic fever(95.4%)
    • benign reproductive system neoplasm(95.4%)
    • Brenner tumor(95.3%)
    • Kyasanur forest disease(95.2%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.